CClinicalTrials.gg
CompletedNCT05435703Updated Jan 5, 2023

Renal Cysts and Primary Aldosteronism

An observational study in Primary Aldosteronism, sponsored by Tampere University Hospital. Completed at 1 site in Finland. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2023-01-05.

Sponsored by Tampere University Hospital · Observational

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
115
Ages
18 Years to 80 Years
Sex
All
01

Study summary

During routine subtyping of confirmed primary aldosteronism by adrenal vein sampling extra plasma samples are drawn from both renal veins and from inferior vena cava. Plasma renin concentration and renin activity are analysed from these samples. Adrenal computed tomographies are analysed for cysts and other possible pathology by a blinded radiologist. Aim is to evaluate correlation between renal pathology and renin measurements.

Read the detailed description

Aim of the study is to evaluate the prevalence of renal cysts and their association with renin concentrationand acitivity in samples from renal veins and inferior vena cava (IVC) in patients who undergo an adrenal vein sampling (AVS) because of primary aldosteronism.

In a prospective study up to 200 patients who have been referred to Tampere University Hospital for AVS are recruited during 24 months. Informed consent is taken. Clinical, medication, radiological and laboratory information according to Endcrine Society guidelines is collected. Interventional radiologist will draw venous blood from both renal veins and from IVC for later renin analyses. One, blinded radiologist will record renal pathology of cysts but also other abnormal radiologic features.

An interim analysis will be done when 60-100 patients have been recruited or at 6-12 months from the start of the study. Study will be stopped if significant difference can be found in renin measurement in patients with renal cysts compared with patients without renal cysts.

02

Conditions studied

  • Primary Aldosteronism

Browse trials for

Keywords

  • Adrenal vein sampling
  • Renal cysts
  • Renin concentration
  • Renin activity
03

In context

Hyperaldosteronism

193 studies on the registry are indexed under Hyperaldosteronism; 89 are open to participants now.

This study's enrollment of 115 is below the median of 200 across 98 observational studies indexed under Hyperaldosteronism.

Browse Hyperaldosteronism studies →

Lead sponsor

Tampere University Hospital is the lead sponsor of 209 studies on the registry; 56 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Adult patients with confirmed primary aldosteronism undergoing subtyping by adrenal vein sampling

Inclusion criteria

  • Confirmed primary aldosteronism according to Endocrine Society guidelines
  • Adrenal vein sampling performed in Tampere University Hospital
  • Informed consent

Exclusion criteria

Exclusion Criteria:

-

05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
115 participants (actual)
Patient registry
No
Biospecimen retention
Samples without dna
06

What researchers measure

Primary outcomes

  1. Association of any renal cyst finding to graded baseline renin concentration (mU/L)

    Number of patients with renal cysts when renin concentration (mU/L) is low, low normal or high normal to high

    Time frame: Baseline

Secondary outcomes

  1. Correlation of renin concentration (mU/L) in inferior vena cava in all patients and in patients with or without renal cysts (or other renal pathology)

    Renin concentration difference (mU/L)

    Time frame: During procedure

  2. Correlation of renin activity (ng of Ang I/ml/h) in inferior vena cava in all patients and in patients with or without renal cysts (or other renal pathology)

    Renin activity difference (ng of Ang I/ml/h)

    Time frame: During procedure

  3. Correlation of renin concentration (mU/l) in right and left renal vein from the side with or without renal cysts (or other renal pathology)

    Concentration difference (mU/l)

    Time frame: During procedure

  4. Correlation of renin activity (ng of Ang I/ml/h) in right and left renal vein from the side with or without renal cysts (or other renal pathology)

    Activity difference (ng of Ang I/ml/h)

    Time frame: During procedure

  5. Prevalence (%) of renal cysts in patients in computed tomography with contrast media

    Prevalence of cysts

    Time frame: Baseline

  6. Association of prevalence of renal cysts (%) with severity of hypertension

    Percentage of patients with renal cysts when patients are grouped according to quartiles of severity of hypertension

    Time frame: Baseline

  7. Association of prevalence of renal cysts (%) with duration (years) of hypertension

    Percentage of patients with renal cysts when patients are grouped according to quartiles of duration of hypertension (years)

    Time frame: Baseline

  8. Association of prevalence of renal cysts (%) with plasma potassium concentration (mmol/l)

    Percentage of patients with renal cysts (%) when patients are grouped according to quartiles of lowest plasma potassium

    Time frame: Baseline

  9. Association of prevalence of renal cysts (%) with severity of primary aldosteronism

    Percentage of patients with renal cysts when patients are grouped according to quartiles of aldosterone to renin ratio (pmol/L)/(mU/L)

    Time frame: Baseline

  10. Renin concentration (mU/l) in renal veins on the side of renal cysts compared with the side with no cysts of each kidney

    Concentration difference

    Time frame: During procedure

  11. Renin concentration (mU/l) in inferior vena cava in patients with renal cysts compared with patients with no cysts

    Concentration difference

    Time frame: During procedure

  12. Renin activity (ng of Ang I/ml/h) in renal veins on the side of renal cysts compared with the side with no cysts

    Activity difference

    Time frame: During procedure

  13. Renin activity (ng of Ang I/ml/h) in inferior vena cava in patients with renal cysts

    Activity difference

    Time frame: During procedure

  14. Association of renal cyst finding to baseline renin concentration (mU/l) in different age groups

    Number of patients with renal cysts when renin concentration is low, low normal or high normal to high

    Time frame: Baseline

07

Study locations

1 site
  • Tampere University Hospital
    Tampere, 33521, Finland
08

References and documents

Individual participant data

Plan to share: Undecided — IPD may not be shareable according to local laws and regulations

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 5, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05435703
Lead sponsor
Tampere University Hospital
Collaborators
Helsinki University Central Hospital, Kuopio University Hospital, Tampere University
Responsible party
Sponsor
First posted
Jun 28, 2022
Start date
Oct 7, 2020
Primary completion
Dec 30, 2021
Completion
Dec 30, 2021
Last update
Jan 5, 2023

Study contacts

Pasi I Nevalainen, MD, PhD
principal investigator · Tampere University Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion